Pulmonary infections in patients with cystic fibrosis: where to now?
D000336:Aerosols; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001991:Bronchitis / Q000209:etiology*; D001996:Bronchopneumonia / Q000209:etiology*; D002442:Ceftazidime / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011379:Prognosis; D011552:Pseudomonas Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000209:etiology*
D000336:Aerosols; D000900:Anti-Bacterial Agents; D002442:Ceftazidime